Outcome of dogs with mast cell tumors in the inguinal or perineal region versus other cutaneous locations: 124 Cases (1990=2001)

Journal of the American Veterinary Medical Association

Volumn 226, Issue 8, 2005, Pages 1368-1374

  Sfiligoi, Gabriella ^a,c   Rassnick, Kenneth M ^a   Scarlett, Janet M ^a   Northrup, Nicole C ^b   Gieger, Tracy L ^b,c  

^a Department of Obstetrics Gynecology   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DOG; DOG DISEASE; FEMALE; INGUINAL REGION; MALE; MASTOCYTOMA; NONHUMAN; OUTCOMES RESEARCH; PERINEUM; RELAPSE; SKIN; SKIN TUMOR; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; SYSTEMIC THERAPY; TUMOR DIAGNOSIS; TUMOR LOCALIZATION; TUMOR VOLUME;

ANIMALS; DISEASE-FREE SURVIVAL; DOG DISEASES; DOGS; FEMALE; GROIN; MALE; MAST-CELL SARCOMA; NEOPLASM RECURRENCE, LOCAL; PERINEUM; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 17144399597     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2005.226.1368     Document Type: Article

References (22)

1. Vail DM, Mast cell tumors. In: Withrow SJ, MacEwen EG, eds. Small animal clinical oncology. Philadelphia: WB Saunders Co, 2001;261-282.
2. Rogers KS. Mast cell tumors: dilemmas of diagnosis and treatment. Vet Clin North Am Small Anim Pract 1996;26:87-102.
3. O'Keefe DA, Couto CG, Burke-Schwartz C, et al. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1987;1:75-80.
4. Moriello KA, Rosenthal RC. Clinical approach to tumors of the skin and subcutaneous tissues. Vet Clin North Am Small Anim Pract 1990;20:1163-1190.
5. O'Keefe DA. Canine mast cell tumors. Vet Clin North Am Small Anim Pract 1990;20:1105-1115.
6. Ogilvie GK, Moore AS. Management of specific disease: mast cell tumors. In: Ogilvie GK, Moore AS, eds. Managing the veterinary cancer patient. Trenton, NJ: Veterinary Learning Systems, 1995;503-518.
7. Thamm DH, Mauldin EA, Vail DM. Prednisone and vinblastine chemotherapy for canine mast cell tumor: 41 cases (1992-1997). J Vet Intern Med 1999;13:491-497.
8. Ginn PE, Fox LE, Brower JC, et al. Immunohistochemical detection of p53 tumor-suppressor protein is a poor indicator of prognosis for canine cutaneous mast cell tumors. Vet Pathol 2000;37:33-39.
9. Turrel JM, Kitchell BE, Miller LM, et al. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 1988;193:936-940.
10. LaDue T, Price GS, Dodge R, et al. Radiation therapy for incompletely resected canine mast cell tumors. Vet Radial Ultrasound 1998;39:57-62.
11. Michels GM, Knapp DW, DeNicola DB, et al. Prognosis following surgical excision of canine cutaneous mast cell tumors with histopathologically tumor-free versus nontumor-free margins: a retrospective study of 31 cases. J Am Anim Hosp Assoc 2002;38: 458-466.
12. Cahalane AK, Payne S, Barber LG, et al. Prognostic factors for survival of dogs with inguinal and perineal mast cell tumors treated surgically with or without adjunctive treatment: 68 cases (1994-2002). J Am Vet Med Assoc 2004;225:401-408.
13. Patnaik AK, Ehler WJ, MacEwen EG. Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984;21:469-474.
14. Dawson B, Trapp RG. Basic and clinical biostatistics. New York: Lange Medical Books/McGraw-Hill, 2001;138-220.
15. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. Belmont, Calif: Lifetime Learning Publications, 1982;448-456.
16. Zemke D, Yamini B, Yuzbasiyan-Gurkan V. Mutations in the juxtamembrane domain of c-KIT are associated with higher grade mast cell tumors in dogs. Vet Pathol 2002;39:529-535.
17. Zavodovskaya R, Chien MB, London CA. Use of kit internal tandem duplications to establish mast cell tumor clonality in 2 dogs. J Vet Int Med 2004;18:915-917.
18. Abadie JJ, Amardeilh MA, Delverdier ME. Immunohistochemical detection of proliferating cell nuclear antigen and Ki-67 in mast cell tumors from dogs. J Am Vet Med Assoc 1999;215:1629-1634.
19. Bostock DE. The prognosis following surgical removal of mastocytomas in dogs. J Small Anim Pract 1973;14:27-41.
20. Jaffe MH, Hosgood G, Taylor HW, et al. Immunohistochemical and clinical evaluation of p53 in canine cutaneous mast cell tumors. Vet Pathol 2000;37:40-46.
21. Gieger TL, Théon AP, Werner JA, et al. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). J Vet intern Med 2003;17:687-692.
22. Larsen AE, Grier RL. Evaluation of canine mast cell tumors for presence of estrogen receptors. Am J Vet Res 1989;50:1779-1780.